دورية أكاديمية
Genetic Mutations Associated with Inflammatory Response Caused by HPV Integration in Oropharyngeal Squamous Cell Carcinoma.
العنوان: | Genetic Mutations Associated with Inflammatory Response Caused by HPV Integration in Oropharyngeal Squamous Cell Carcinoma. |
---|---|
المؤلفون: | Atique M; Department of Otolaryngology and Head and Neck Surgery, McGill University, Montreal, QC H3T 1E2, Canada.; Segal Cancer Centre and Lady Davis Institute for Medical Research, Departments of Medicine and Oncology, Sir Mortimer B. Davis-Jewish General Hospital, Faculty of Medicine, McGill University, Montreal, QC H3T 1E2, Canada., Muniz I; Department of Otolaryngology and Head and Neck Surgery, McGill University, Montreal, QC H3T 1E2, Canada.; Segal Cancer Centre and Lady Davis Institute for Medical Research, Departments of Medicine and Oncology, Sir Mortimer B. Davis-Jewish General Hospital, Faculty of Medicine, McGill University, Montreal, QC H3T 1E2, Canada.; Graduate Program in Dentistry, Health Sciences Center, Federal University of Paraiba, Campus I, João Pessoa 58051-900, PB, Brazil., Farshadi F; Department of Otolaryngology and Head and Neck Surgery, McGill University, Montreal, QC H3T 1E2, Canada.; Segal Cancer Centre and Lady Davis Institute for Medical Research, Departments of Medicine and Oncology, Sir Mortimer B. Davis-Jewish General Hospital, Faculty of Medicine, McGill University, Montreal, QC H3T 1E2, Canada., Hier M; Department of Otolaryngology and Head and Neck Surgery, McGill University, Montreal, QC H3T 1E2, Canada., Mlynarek A; Department of Otolaryngology and Head and Neck Surgery, McGill University, Montreal, QC H3T 1E2, Canada., Macarella M; Department of Otolaryngology and Head and Neck Surgery, McGill University, Montreal, QC H3T 1E2, Canada., Maschietto M; Department of Structural and Functional Biology, Institute of Biology, Universidade Estadual de Campinas (UNICAMP), Campinas 13084-225, SP, Brazil.; Boldrini Children's Center, Campinas 13084-225, SP, Brazil., Nicolau B; Graduate Program in Dentistry, Health Sciences Center, Federal University of Paraiba, Campus I, João Pessoa 58051-900, PB, Brazil., Alaoui-Jamali MA; Segal Cancer Centre and Lady Davis Institute for Medical Research, Departments of Medicine and Oncology, Sir Mortimer B. Davis-Jewish General Hospital, Faculty of Medicine, McGill University, Montreal, QC H3T 1E2, Canada., da Silva SD; Department of Otolaryngology and Head and Neck Surgery, McGill University, Montreal, QC H3T 1E2, Canada.; Segal Cancer Centre and Lady Davis Institute for Medical Research, Departments of Medicine and Oncology, Sir Mortimer B. Davis-Jewish General Hospital, Faculty of Medicine, McGill University, Montreal, QC H3T 1E2, Canada. |
المصدر: | Biomedicines [Biomedicines] 2023 Dec 21; Vol. 12 (1). Date of Electronic Publication: 2023 Dec 21. |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101691304 Publication Model: Electronic Cited Medium: Print ISSN: 2227-9059 (Print) Linking ISSN: 22279059 NLM ISO Abbreviation: Biomedicines Subsets: PubMed not MEDLINE |
أسماء مطبوعة: | Original Publication: Basel, Switzerland : MDPI AG, [2013]- |
مستخلص: | (1) Background: Head and neck cancer (HNC) ranks as the sixth most prevalent cancer in the world. In addition to the traditional risk factors such as alcohol and tobacco consumption, the implication of the human papillomavirus (HPV) is becoming increasingly significant, particularly in oropharyngeal cancer (OPC). (2) Methods: This study is based on a review analysis of different articles and repositories investigating the mutation profile of HPV-related OPC and its impact on patient outcomes. (3) Results: By compiling data from 38 datasets involving 8311 patients from 12 countries, we identified 330 genes that were further analyzed. These genes were enriched for regulation of the inflammatory response ( RB1 , JAK2 , FANCA , CYLD , SYK , ABCC1 , SYK , BCL6 , CEBPA , SRC , BAP1 , FOXP1 , FGR , BCR , LRRK2 , RICTOR , IGF1 , and ATM ), among other biological processes. Hierarchical cluster analysis showed the most relevant biological processes were linked with the regulation of mast cell cytokine production, neutrophil activation and degranulation, and leukocyte activation (FDR < 0.001; p -value < 0.05), suggesting that neutrophils may be involved in the development and progression of HPV-related OPC. (4) Conclusions: The neutrophil infiltration and HPV status emerge as a potential prognostic factor for OPC. HPV-infected HNC cells could potentially lead to a decrease in neutrophil infiltration. By gaining a better molecular understanding of HPV-mediated neutrophil immunosuppression activity, it is possible to identify a meaningful target to boost antitumor immune response in HNC and hence to improve the survival of patients with HNC. |
References: | J Hematol Oncol. 2021 Oct 21;14(1):173. (PMID: 34674757) Hum Vaccin Immunother. 2019;15(7-8):1920-1928. (PMID: 31050595) Eur Arch Otorhinolaryngol. 2020 Sep;277(9):2407-2412. (PMID: 32342197) Mol Cancer Res. 2022 Sep 2;20(9):1420-1428. (PMID: 35657601) Am J Otolaryngol. 2012 Jan-Feb;33(1):130-6. (PMID: 21546122) BMC Cancer. 2013 Dec 17;13:602. (PMID: 24341335) J Immunol Res. 2015;2015:983698. (PMID: 26819959) Virology. 2009 Feb 20;384(2):375-9. (PMID: 19064276) Oral Oncol. 2016 Mar;54:36-41. (PMID: 26786940) Cancers (Basel). 2020 Apr 25;12(5):. (PMID: 32344813) Cancer Med. 2017 Jul;6(7):1673-1685. (PMID: 28556593) Cancers (Basel). 2021 Dec 16;13(24):. (PMID: 34944929) Mod Pathol. 2021 Feb;34(2):358-370. (PMID: 32892208) Semin Radiat Oncol. 2018 Jan;28(1):2-11. (PMID: 29173752) Cancer. 2018 Jan 1;124(1):84-94. (PMID: 29053175) Vaccines (Basel). 2023 May 26;11(6):. (PMID: 37376417) Cancer Causes Control. 2016 Jun;27(6):809-15. (PMID: 27097911) Cancer Med. 2021 Feb;10(4):1347-1356. (PMID: 33527763) Genes Cancer. 2011 Apr;2(4):466-74. (PMID: 21779514) Int J Cancer. 2019 Dec 1;145(11):3152-3162. (PMID: 31093971) Science. 2011 Aug 26;333(6046):1157-60. (PMID: 21798893) Virchows Arch. 1995;427(2):153-7. (PMID: 7582245) Mol Cancer. 2019 Feb 19;18(1):26. (PMID: 30782187) BMJ. 2021 Mar 29;372:n71. (PMID: 33782057) Sci Rep. 2020 Oct 6;10(1):16634. (PMID: 33024167) Methods Mol Biol. 2014;1124:3-10. (PMID: 24504942) Cells. 2021 Sep 20;10(9):. (PMID: 34572138) J Clin Med. 2018 Aug 27;7(9):. (PMID: 30150513) Radiother Oncol. 2016 Feb;118(2):342-9. (PMID: 26952933) DNA Repair (Amst). 2015 Jul;31:64-72. (PMID: 26001739) Cell Cycle. 2009 May 1;8(9):1352-8. (PMID: 19305151) Int J Mol Sci. 2022 Mar 16;23(6):. (PMID: 35328639) Am J Surg Pathol. 2010 Aug;34(8):1088-96. (PMID: 20588174) Cancer Res. 2021 Sep 1;81(17):4402-4416. (PMID: 34167951) J Clin Oncol. 2006 Dec 20;24(36):5630-6. (PMID: 17179101) PLoS One. 2020 Sep 28;15(9):e0238497. (PMID: 32986729) Sci Rep. 2021 Mar 11;11(1):5661. (PMID: 33707570) Front Oncol. 2019 Nov 15;9:1146. (PMID: 31799175) Cancer. 2020 Jan 1;126(1):76-85. (PMID: 31584709) Trends Immunol. 2019 Jul;40(7):565-583. (PMID: 31160207) Int J Biol Sci. 2020 Feb 4;16(6):1035-1043. (PMID: 32140071) Front Physiol. 2018 Feb 20;9:113. (PMID: 29515456) Nat Rev Cancer. 2020 Sep;20(9):485-503. (PMID: 32694624) Viruses. 2017 Aug 03;9(8):. (PMID: 28771189) Clin Cancer Res. 2014 May 1;20(9):2300-11. (PMID: 24599934) Oral Oncol. 2019 Jun;93:59-65. (PMID: 31109697) Br J Cancer. 2020 Feb;122(3):306-314. (PMID: 31708575) Cancer Res Treat. 2019 Jan;51(1):300-312. (PMID: 29747488) BMC Cancer. 2018 Jun 7;18(1):640. (PMID: 29879932) Oncogene. 2008 Oct 6;27(45):5904-12. (PMID: 18836471) J Clin Oncol. 2011 Nov 10;29(32):4294-301. (PMID: 21969503) Blood Adv. 2019 Nov 26;3(22):3562-3574. (PMID: 31738831) Head Neck Pathol. 2015 Jun;9(2):223-35. (PMID: 25236499) Pathol Oncol Res. 2019 Jul;25(3):1047-1058. (PMID: 30099696) Mol Cancer. 2017 Aug 15;16(1):137. (PMID: 28810877) JCI Insight. 2018 Jul 26;3(14):. (PMID: 30046007) Front Immunol. 2020 Apr 28;11:532. (PMID: 32411122) Histopathology. 2021 Sep;79(3):381-390. (PMID: 33560536) Sci Rep. 2019 Dec 23;9(1):19673. (PMID: 31873162) Nat Genet. 2014 Sep;46(9):939-43. (PMID: 25086664) Cancer. 2019 Jul 15;125(14):2423-2434. (PMID: 30933315) J Clin Oncol. 2014 Oct 20;32(30):3365-73. (PMID: 24958820) Curr Oncol Rep. 2019 Apr 17;21(6):52. (PMID: 30997577) Br Dent J. 2022 Nov;233(9):780-786. (PMID: 36369568) Ann Oncol. 2015 Jun;26(6):1216-1223. (PMID: 25712460) EBioMedicine. 2019 Jul;45:70-80. (PMID: 31255659) Asian Pac J Cancer Prev. ;18(6):1543-1548. (PMID: 28669165) Int Immunol. 2021 Mar 1;33(3):127-148. (PMID: 33337480) iScience. 2022 Apr 06;25(5):104216. (PMID: 35494251) ANZ J Surg. 2012 May;82(5):362-6. (PMID: 22507644) Syst Rev. 2016 Dec 5;5(1):210. (PMID: 27919275) Sci Rep. 2018 Jul 30;8(1):11458. (PMID: 30061624) Cancer Cell Int. 2021 Dec 24;21(1):703. (PMID: 34952583) BMC Cancer. 2019 Jul 9;19(1):674. (PMID: 31288767) Eur J Cancer. 2018 Mar;91:47-55. (PMID: 29331751) Front Oral Health. 2021 Feb 11;2:604565. (PMID: 35047989) J Cancer Res Clin Oncol. 2023 Jan;149(1):69-77. (PMID: 36117189) Curr Top Microbiol Immunol. 2010;347:79-104. (PMID: 20582532) Clin Cancer Res. 2015 Feb 1;21(3):632-41. (PMID: 25056374) Cancers (Basel). 2021 Nov 23;13(23):. (PMID: 34884999) Cancers (Basel). 2021 Oct 17;13(20):. (PMID: 34680354) Sci Rep. 2020 Aug 6;10(1):13203. (PMID: 32764699) Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1053-9. (PMID: 19577857) Clin Microbiol Rev. 2003 Jan;16(1):1-17. (PMID: 12525422) Semin Radiat Oncol. 2012 Jul;22(3):187-93. (PMID: 22687942) Pathol Oncol Res. 2020 Apr;26(2):1191-1199. (PMID: 31197568) J Oral Pathol Med. 2015 Oct;44(9):734-45. (PMID: 25495427) BMC Cancer. 2018 Apr 4;18(1):383. (PMID: 29618336) Anticancer Res. 2013 Mar;33(3):1215-20. (PMID: 23482805) Hered Cancer Clin Pract. 2013 Jun 15;11(1):5. (PMID: 23768168) |
معلومات مُعتمدة: | 2020-2025 CIHR; 2023-2024 RSBO-FRQS |
فهرسة مساهمة: | Keywords: head and neck cancer; human papillomavirus; mutational profile; oropharyngeal squamous cell carcinomas; prognosis |
تواريخ الأحداث: | Date Created: 20240126 Latest Revision: 20240128 |
رمز التحديث: | 20240128 |
مُعرف محوري في PubMed: | PMC10813733 |
DOI: | 10.3390/biomedicines12010024 |
PMID: | 38275384 |
قاعدة البيانات: | MEDLINE |
تدمد: | 2227-9059 |
---|---|
DOI: | 10.3390/biomedicines12010024 |